The invention relates to the treatment and prophylaxis of cancer. In
particular, the invention relates to a pharmaceutical agent comprising
strontium, amino acid(s) and mineral element(s), and its use in the
preparation of an agent useful for the treatment and prophylaxis of
cancer. The invention also relates to a method for treatment and
prophylaxis of cancer.